About SG Americas Securities
SG Americas Securities is a venture capital firm founded in 2003. It is primarily based out of New York City, United States. As of Jan 2022, SG Americas Securities has invested in 6 companies. It primarily invests in Post IPO round in United States based startups. Its investments are spread across a wide range of sectors from Life Sciences to Enterprise Applications and High Tech. Most recently it participated in the $***** Post IPO round of Immunovant Overall, SG Americas Securities portfolio has seen 6 IPOs including key companies like OncoCyte, Amdocs and Sprint. A lot of funds co-invest with SG Americas Securities, with names like Societe Generale sharing a substantial percentage of its portfolio. SG Americas Securities has team of 2 people.Key Metrics
Team Members
Portfolio Sectors
Portfolio Locations
Rounds of Entry
Post IPO & Conventional Debt
Portfolio IPOs
SG Americas Securities' List of Top Investments
SG Americas Securities has a portfolio of 6 companies. Their most notable investments include OncoCyte and Amdocs.Their portfolio spans across United States, Canada and Switzerland. They have invested in Life Sciences, Enterprise Applications, High Tech and 3 other sectors, across stages such as Post IPO, Conventional Debt stages. Here is the list of top investments by SG Americas Securities:
1. OncoCyte
Developer of non-invasive diagnostic test solutions for the treatment of cancer. The company has developed DetermaRx for non-squamous NSCLC and DetermaRx + EGFR for early-stage NSCLC testing. The platform analyzes both blood and urine samples for specific cancer biomarkers using an algorithm to compare gene expression patterns with a database of gene expression patterns of known cancers. It can be used to identify lung, breast, and bladder cancer.
Key facts about OncoCyte
- Founded Year: 2009
- Location: Irvine (United States)
- Annual Revenue: $1M - $10M as on Dec 31, 2024
- Stage: Public
- Total Funding till date: $15.3M
- Employee Count: 63 as on Mar 31, 2026
- Investors: Geode Capital, Connor, Clark & Lunn Financial Group and 5 Others
- Latest Funding Round: Post IPO, Feb 10, 2025, $*****
- Highlight: Public
2. Amdocs
Cloud-based OSS and BSS solutions provider. It offers customer-experience software solutions to communications and media service providers. Its offerings include BSS, OSS, NFV, Big Data, customer experiences, OTT monetization, and more.
Key facts about Amdocs
- Founded Year: 1982
- Location: Chesterfield (United States)
- Stage: Public
- Employee Count: 10,000 - 1,000,000 as on Mar 01, 2026
- Investors: Norwest, SG Americas Securities and 5 Others
- Highlight: Public
3. Sprint
Sprint, is an American telecommunications holding company that provides wireless services and is a major global Internet carrier. It is the fourth largest wireless network operator in the United States, and serves 58.4 million customers as of January 2016. Was rated No. 1 among all national carriers by The American Customer Satisfaction Index in customer satisfaction and most improved, across all 47 industries.Prior to 2005, the company was also known as the Sprint Corporation, but took the name Sprint Nextel Corporation when it merged with Nextel Communications that year. In 2013 the company recorded annual revenues of $35.34B and a net loss of $4.32B
Key facts about Sprint
- Founded Year: 1899
- Location: Overland Park (United States)
- Annual Revenue: $1B+ as on Dec 31, 2012
- Stage: Public
- Employee Count: 37,005 as on May 31, 2026
- Investors: SG Americas Securities, GPI Capital and 3 Others
- Latest Funding Round: Conventional Debt, Mar 21, 2018, $*****
- Highlight: Public
_1559803909206.png?format=webp&height=120&width=120){kind=logo}
4. Immunovant
Provider of therapeutic solutions to treating autoimmune diseases. The company's product line include, IMVT-1401, is a human recombinant anti-FcRn monoclonal antibody that is being developed with a focus on patient needs and a range of autoimmune diseases. The candidate is meant for diseases like Myasthenia Gravis, and Graves’ Ophthalmopathy.
Key facts about Immunovant
- Founded Year: 2016
- Location: New York City (United States)
- Stage: Public
- Employee Count: 279 as on Aug 31, 2026
- Investors: Colt Ventures, RTW Investments and 4 Others
- Latest Funding Round: Post IPO, Jan 13, 2025, $*****
- Highlight: Public
In 2022, the company recorded annual revenues of $1.1B and a net profit of $0.18B.
Key facts about Columbia Bank
- Founded Year: 1927
- Location: Fair Lawn (United States)
- Stage: Public
- Employee Count: 796 as on Aug 31, 2026
- Investors: SG Americas Securities
- Highlight: Public
SG Americas Securities' Year-on-Year Investment Trends
SG Americas Securities has invested in 6 companies over the last 8 years, with an average of 0 new investment annually in the last 5 years. Its most recent first time investment was in Immunovant.Year | No. of Investments | ||
|---|---|---|---|
1st Round | Follow-on | Total | |
2026 (YTD) | 0 | 0 | 0 |
2025 | 0 | 0 | 0 |
2024 | 0 | 0 | 0 |
2023 | 0 | 0 | 0 |
2022 | 1 | 0 | 1 |
2021 | 1 | 0 | 1 |
2020 | 0 | 0 | 0 |
2019 | 0 | 0 | 0 |
2018 | 1 | 0 | 1 |
SG Americas Securities' Investments by Stage
SG Americas Securities has made 2 investments in Post IPO stage and 1 investment in Conventional Debt stage with an average round size of $350M.Stage of entry | No. of Investments |
|---|---|
Post IPO | 2 |
Conventional Debt | 1 |
Note: We have considered here, only first round of investments
SG Americas Securities' Investments by Sector
SG Americas Securities has a diverse portfolio, with companies operating in the Life Sciences, High Tech and Mining. Notably, it has invested in 5 Enterprise (B2B) companies, 3 Tech companies, 2 Consumer (B2C) companies and at least 1 company focusing on Saas.Sector | No. of Investments |
|---|---|
Life Sciences | 2 |
High Tech | 1 |
Mining | 1 |
Note: We have considered here, only first round of investments
SG Americas Securities' Investments by Geography
SG Americas Securities has made most investments in United States (2), followed by Canada where it has made 1 investment.Country | No. of Investments |
|---|---|
United States | 2 |
Canada | 1 |
Switzerland | 1 |
Note: We have considered here, only first round of investments
SG Americas Securities' recent investments
SG Americas Securities has not made any investment in 2026 so far.Here are the most recent investments by SG Americas Securities:
Filter this listDate | Company | Location | Round Details | Round Amount | Co-Investors |
|---|---|---|---|---|---|
Jan 23, 2022 | United States | Post IPO | 3776 | - | |
2021 | United States | Post IPO | 9506 | - | |
Jul 09, 2018 | Canada | Conventional Debt | 4661 | [+6] |
IPOs and Publicly Listed companies in SG Americas Securities' Portfolio
6 of SG Americas Securities' portfolio companies have become public. Immunovant got listed on the National Association of Securities Dealers Automated Quotations (NASDAQ), in Dec 2019 at marketcap of $200M and Columbia Bank got listed on the National Association of Securities Dealers Automated Quotations (NASDAQ).Here are SG Americas Securities' portfolio companies that went public:
Company | IPO Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Dec 19, 2019 | Jan 23, 2022 | Post IPO | 2725 | |
Apr 20, 2018 | - | - | 1121 | |
Jul 23, 2015 | 2021 | Post IPO | 2443 | |
Dec 19, 2014 | Jul 09, 2018 | Conventional Debt | 8869 | |
Jul 12, 2013 | - | - | 9562 |
_1559803909206.png?devicePixelRatio=2&height=20&width=20){kind=logo}
Team profile of SG Americas Securities
SG Americas Securities has a team of 2 members located in United States. SG Americas Securities' team does not sit on the board of any company as of now.Co-investors of SG Americas Securities
Over the past 8 years, 19 investors have co-invested in SG Americas Securities's portfolio companies. This includes only funds.
- Invested before SG Americas Securities: Pura Vida Investments, RTW Investments and 11 others have invested in rounds before SG Americas Securities. There is 1 company where Pura Vida Investments has invested before SG Americas Securities and 1 company where RTW Investments has invested before SG Americas Securities.
- Top Co-investors of SG Americas Securities: 6 investors entered a company along with SG Americas Securities. These include investors like Societe Generale (1 company).
Recent News related to SG Americas Securities
•
SG Americas Securities LLC Trims Stock Position in Vera Therapeutics, Inc. $VERAAmerican Banking News•Jul 09, 2026•SG Americas Securities
•
SG Americas Securities LLC Invests $281,000 in Viasat Inc. (NASDAQ:VSAT)MarketBeat•Jun 27, 2025•ViaSat, SG Americas Securities
•
SG Americas Securities LLC Acquires 44,753 Shares of Host Hotels & Resorts, Inc. (NASDAQ:HST)MarketBeat•Jun 19, 2025•SG Americas Securities, Host Hotels & Resorts
•
41,638 Shares in Tutor Perini Corporation (NYSE:TPC) Acquired by SG Americas Securities LLCMarketBeat•Jun 19, 2025•SG Americas Securities, Tutor Perini
•
SG Americas Securities LLC Invests $922,000 in Ambarella, Inc. (NASDAQ:AMBA)MarketBeat•Jun 19, 2025•Ambarella, SG Americas Securities
•
SG Americas Securities LLC Invests $954,000 in Enterprise Products Partners L.P. (NYSE:EPD)MarketBeat•Jun 19, 2025•SG Americas Securities, Enterprise Products
•
Procore Technologies, Inc. (NYSE:PCOR) Shares Acquired by SG Americas Securities LLCMarketBeat•Jun 19, 2025•SG Americas Securities, Procore
•
Box, Inc. (NYSE:BOX) Shares Acquired by SG Americas Securities LLCMarketBeat•Jun 19, 2025•SG Americas Securities, Box
•
SG Americas Securities LLC Invests $966,000 in Concentra Group Holdings Parent, Inc. (NYSE:CON)MarketBeat•Jun 19, 2025•SG Americas Securities, Concentra
•
SG Americas Securities LLC Acquires 67,992 Shares of Leggett & Platt, Incorporated (NYSE:LEG)MarketBeat•Jun 19, 2025•SG Americas Securities, Leggett & Platt
